New Protein Discovery Opens Door to Schizophrenia Treatment

Northwestern University researchers discovered a biomarker that could finally treat the cognitive symptoms of schizophrenia that current medications miss.

A synthetic protein tested in animal models successfully reversed brain abnormalities linked to memory and thinking problems.